Literature DB >> 29348090

Pharmacological validation of the folkloric uses of Cyperus rotundus L. in different ailments: An in vivo and in vitro research.

Musaddique Hussain1, Hafiz Muhammad Waqas2, Ikhlaq Hussain3, Abdul Majeed4, Shahid Masood Raza2, Khalid Hussain Janbaz4.   

Abstract

In vivo and in vitro research study was conducted on Cyperus rotundus to evaluate the sound mechanistic background in the treatment of gastrointestinal, bronchial and vascular disorders as well as in pain, emesis, pyrexia and bacterial infections. Results showed that crude extract of Cyperus rotundus (Cr.Cr) exhibited the dose-dependent spasmolytic effect in rabbit jejunum by inhibiting the spontaneous and K+ (80 mM)-induced contractions. Pretreatment of tissue with Cr. Cr caused the rightward shift of calcium concentration response curves, similar to verapamil. Cr. Cr also caused the relaxation of K+(80 mM)- and carbachol (1 µM)-induced contractions of trachea preparations, similar to that of verapamil. Moreover, Cr. Cr also relaxed the contraction induced by the K+ (80 mM) and phenylephrine (1 µM) of aorta preparations. Data show that C. rotundus possess the spasmolytic, bronchodilator and vasodilator activities possibly through calcium channels blockade; validating its folkloric use in diarrhea, dyspepsia, bronchitis, asthma and hypertension in addition to antibacterial, antiemetic, antipyretic and analgesic activities.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29348090

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  2 in total

1.  Antipyretic potential of dichloromethane leaf extract of Eucalyptus globulus (Labill) and Senna didymobotrya (Fresenius) in rats models.

Authors:  Joseph Kiambi Mworia; Cromwell Mwiti Kibiti; Mathew Piero Ngugi; Joseph Ngari Ngeranwa
Journal:  Heliyon       Date:  2019-12-07

Review 2.  Cyperus spp.: A Review on Phytochemical Composition, Biological Activity, and Health-Promoting Effects.

Authors:  Yasaman Taheri; Jesús Herrera-Bravo; Luis Huala; Luis A Salazar; Javad Sharifi-Rad; Muhammad Akram; Khuram Shahzad; Guiomar Melgar-Lalanne; Navid Baghalpour; Katayoun Tamimi; Javad Mahroo-Bakhtiyari; Dorota Kregiel; Abhijit Dey; Manoj Kumar; Hafiz Ansar Rasul Suleria; Natália Cruz-Martins; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-09-07       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.